BB Good human data, but mixed outcomes or surrogate markers. How we grade →RCT (MASTERS) · 94 adults aged 65 and older, 14 weeks of resistance training
Metformin blunts muscle hypertrophy in response to progressive resistance exercise training in older adults: A randomized, double-blind, placebo-controlled, multicenter trial: The MASTERS trial
R Walton, C Dungan, D Long, S Tuggle, K Kosmac, B Peck et al. Aging Cell. 2019.
- In plain language
- Placebo gained more lean body mass and thigh muscle than metformin (1,700 mg a day) during resistance training.
- Limits
- 14 weeks; strength differences not significant; NIA funded.
- Which of our grades it feeds
- DD Mostly mechanistic or early data. Shown openly. How we grade →Science summary: Metformin as an aging drug: what the evidence shows, and why the TAME trial has not started
- Source
- doi.org/10.1111/acel.13039 · PubMed 31557380 · Free full text
Summary written by Everstack from the published abstract. Verified against Crossref on 2026-10-15. The authors do not endorse Everstack. We sell some of what we grade.